NYSE ARCA | ETF
The fund is an actively-managed exchange-traded fund ("ETF").
The adviser seeks to achieve the fund"s investment objective by investing, under normal circumstances, at least 80% of its net assets in the equity securities ofU. S. companies.
The fund invests in companies that are determined to be attractive by the adviser with an emphasis on income generation.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| AAPL | Apple Inc | Technology | Consumer Electronics | 7.40% |
| NVDA | NVIDIA Corporation | Technology | Semiconductors | 6.70% |
| MSFT | Microsoft Corporation | Technology | Software - Infrastructure | 5.77% |
| AMZN | Amazon.com Inc | Consumer Cyclical | Internet Retail | 2.76% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.24% |
| GOOGL | Alphabet Inc Class A | Communication Services | Internet Content & Information | 1.98% |
| META | Meta Platforms Inc. | Communication Services | Internet Content & Information | 1.81% |
| ADBE | Adobe Systems Incorporated | Technology | Software - Infrastructure | 1.47% |
| NFLX | Netflix Inc | Communication Services | Entertainment | 1.39% |
| CVX | Chevron Corp | Energy | Oil & Gas Integrated | 1.37% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.37% |
| ORCL | Oracle Corporation | Technology | Software - Infrastructure | 1.37% |
| KO | The Coca-Cola Company | Consumer Defensive | Beverages - Non-Alcoholic | 1.36% |
| WFC | Wells Fargo & Company | Financial Services | Banks - Diversified | 1.33% |
| IBM | International Business Machines | Technology | Information Technology Services | 1.27% |
| CSCO | Cisco Systems Inc | Technology | Communication Equipment | 1.25% |
| PEP | PepsiCo Inc | Consumer Defensive | Beverages - Non-Alcoholic | 1.22% |
| QCOM | Qualcomm Incorporated | Technology | Semiconductors | 1.18% |
| PM | Philip Morris International Inc | Consumer Defensive | Tobacco | 1.16% |
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 1.15% |